In BNCT experiments with glioma U87 delta EGFR cells showed similar survival rates with SCC VII; Survival rates of U87 delta EGFR cells were 24.2 ± 7.7% and 6.2 ± 1.4% for the group treated with 20 ppm of 10B in BPA, and 3.0 ± 0.4 % and 0 % for the group treated with 0.7 ppm of 10B in hydroxamate 2 (B2) when irradiated with thermal neutron fluence of 1.5 × 1012 cm−2, and 2.7 × 1012 cm−2, respectively (Figure 7). The gene discussed is EGFR; the disease is glioma.